| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |